Getting it first versus getting it right: weighing the value of and evidence for progression-free survival as a surrogate endpoint for overall survival in glioblastoma | Zendy

AI Assistant Blog Pricing

Getting it first versus getting it right: weighing the value of and evidence for progression-free survival as a surrogate endpoint for overall survival in glioblastoma

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.